RUSSELL FRANK CO/ - ACHILLION PHARMACEUTICALS IN ownership

ACHILLION PHARMACEUTICALS IN's ticker is ACHN and the CUSIP is 00448Q201. A total of 162 filers reported holding ACHILLION PHARMACEUTICALS IN in Q3 2014. The put-call ratio across all filers is 0.24 and the average weighting 0.1%.

Quarter-by-quarter ownership
RUSSELL FRANK CO/ ownership history of ACHILLION PHARMACEUTICALS IN
ValueSharesWeighting
Q1 2016$146,000
-91.6%
18,892
-86.6%
0.00%
-100.0%
Q4 2014$1,736,000
+8.8%
141,224
-11.6%
0.00%0.0%
Q3 2014$1,595,000
+2472.6%
159,832
+1765.2%
0.00%
Q3 2013$62,000
-10.1%
8,569
+1.7%
0.00%
Q2 2013$69,0008,4240.00%
Other shareholders
ACHILLION PHARMACEUTICALS IN shareholders Q3 2014
NameSharesValueWeighting ↓
RA Capital Management 6,700,000$82,075,0008.82%
RTW INVESTMENTS, LP 1,622,633$19,877,0007.35%
ProQuest Associates IV LLC 1,122,957$13,757,0006.97%
RA Capital Management 2,500,000$30,625,0003.29%
DOHENY ASSET MANAGEMENT /CA 517,450$6,339,0003.03%
DAFNA Capital Management LLC 197,500$2,419,0001.91%
Rhenman & Partners Asset Management AB 368,000$4,508,0001.31%
SECTORAL ASSET MANAGEMENT INC 2,373,810$29,079,0001.30%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 2,920,300$35,774,0001.28%
Bain Capital Public Equity Management, LLC 2,928,750$35,877,0000.90%
View complete list of ACHILLION PHARMACEUTICALS IN shareholders